WC Walker & Associates’s Labcorp LH Stock Holding History

WC Walker & Associates’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-839	Closed	-$203K	–	74
2021 Q3	$203K	Hold	839	–	–	0.11%	66
2021 Q2	$200K	Buy	+839	New	+$191K	0.1%	68

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WC Walker & Associates's LH Position: Q4 2021 in Review

WC Walker & Associates sold out of Labcorp (LH) in Q4 2021, closing a stake of 839 shares — an estimated $203K sold.

WC Walker & Associates first reported a position in LH in Q2 2021 and held it in 2 quarters. The position peaked at $203K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

WC Walker & Associates reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
WC Walker & Associates sold 839 Labcorp shares in Q4 2021, an estimated $203K.
WC Walker & Associates first reported a position in Labcorp in Q2 2021 and held it in 2 quarters.
WC Walker & Associates's Labcorp position peaked at $203K in Q3 2021.
1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on WC Walker & Associates's 13F filing for Q4 2021, filed 18 Jan 2022.